Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.4033 USD
−26.08 M USD
31.91 M USD
26.30 M
About Enzo Biochem, Inc.
Sector
Industry
CEO
Kara Cannon
Website
Headquarters
New York
Founded
1976
FIGI
BBG000BHYJC7
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENZB is 0.6817 USD — it has increased by 0.24% in the past 24 hours. Watch Enzo Biochem, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Enzo Biochem, Inc. stocks are traded under the ticker ENZB.
ENZB stock has fallen by −0.33% compared to the previous week, the month change is a 28.63% rise, over the last year Enzo Biochem, Inc. has showed a −41.23% decrease.
ENZB reached its all-time high on Jan 24, 2000 with the price of 94.0799 USD, and its all-time low was 0.0658 USD and was reached on Jun 16, 1980. View more price dynamics on ENZB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENZB stock is 0.26% volatile and has beta coefficient of 2.54. Track Enzo Biochem, Inc. stock price on the chart and check out the list of the most volatile stocks — is Enzo Biochem, Inc. there?
Yes, you can track Enzo Biochem, Inc. financials in yearly and quarterly reports right on TradingView.
Enzo Biochem, Inc. is going to release the next earnings report on Oct 21, 2025. Keep track of upcoming events with our Earnings Calendar.
ENZB net income for the last quarter is −2.79 M USD, while the quarter before that showed −1.53 M USD of net income which accounts for −81.76% change. Track more Enzo Biochem, Inc. financial stats to get the full picture.
As of Jul 19, 2025, the company has 136 employees. See our rating of the largest employees — is Enzo Biochem, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Enzo Biochem, Inc. EBITDA is −8.54 M USD, and current EBITDA margin is −26.52%. See more stats in Enzo Biochem, Inc. financial statements.
Like other stocks, ENZB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enzo Biochem, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enzo Biochem, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enzo Biochem, Inc. stock shows the sell signal. See more of Enzo Biochem, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.